Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Type IV pili (T4P) are multifunctional, filamentous surface appendages that are critical for the virulence and environmental adaptation of Pseudomonas aeruginosa (1.3.1, 1.3.3). These structures are primarily composed of polymerized PilA subunits and are dynamic, undergoing cycles of extension and retraction powered by the ATPases PilB and PilT, respectively (1.2.2, 1.5.1). This dynamic action facilitates twitching motility, a form of surface-associated movement that allows the bacteria to navigate host surfaces and aggregate into microcolonies (1.1.2, 1.3.1). T4P also serve as essential adhesins, mediating the initial attachment of P. aeruginosa to host epithelial cells, which is a prerequisite for colonization and subsequent infection (1.3.1, 1.3.3). In addition to motility and adhesion, T4P play a significant role in biofilm maturation and the uptake of horizontal genetic material through natural transformation (1.3.3, 1.3.4). They also act as the primary receptors for many lytic bacteriophages, making them a focal point for phage therapy development (1.1.3, 1.3.5). Therapeutic strategies targeting T4P include monoclonal antibodies designed to inhibit adhesion or promote opsonophagocytosis, as well as small molecules that disrupt the assembly machinery (1.3.1, 1.4.1). By targeting these pili, researchers aim to reduce bacterial pathogenicity and biofilm-associated antibiotic tolerance, providing a potent anti-virulence approach against multidrug-resistant P. aeruginosa strains (1.3.1, 1.3.4).
Inhibition of pilus assembly and retraction, blocking of bacterial adhesion to host tissues, and facilitation of lytic bacterial destruction through phage-mediated entry (1.3.1, 1.3.5, 1.4.1).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Type IV pili (T4P) (T4P).